Oakbrook Investments’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-12,116
| Closed | -$1.76M | – | 532 |
|
|
2019
Q4 | $1.76M | Sell |
12,116
-4,583
| -27% | -$666K | 0.36% | 45 |
|
|
2019
Q3 | $2.23M | Sell |
16,699
-2,575
| -13% | -$343K | 0.14% | 100 |
|
|
2019
Q2 | $2.2M | Sell |
19,274
-26
| -0.1% | -$2.97K | 0.13% | 109 |
|
|
2019
Q1 | $2.39M | Hold |
19,300
| – | – | 0.15% | 114 |
|
|
2018
Q4 | $1.94M | Sell |
19,300
-1,782
| -8% | -$179K | 0.13% | 119 |
|
|
2018
Q3 | $2.69M | Buy |
21,082
+5,047
| +31% | +$644K | 0.15% | 113 |
|
|
2018
Q2 | $1.74M | Buy |
16,035
+204
| +1% | +$22.1K | 0.11% | 137 |
|
|
2018
Q1 | $1.68M | Buy |
15,831
+999
| +7% | +$106K | 0.1% | 151 |
|
|
2017
Q4 | $1.74M | Sell |
14,832
-180
| -1% | -$21.1K | 0.11% | 138 |
|
|
2017
Q3 | $1.71M | Sell |
15,012
-1,473
| -9% | -$167K | 0.11% | 151 |
|
|
2017
Q2 | $2.06M | Buy |
16,485
+7,962
| +93% | +$993K | 0.14% | 130 |
|
|
2017
Q1 | $1.01M | Buy |
+8,523
| New | +$1.01M | 0.07% | 224 |
|
|
2016
Q2 | – | Sell |
-10,171
| Closed | -$1.05M | – | 595 |
|
|
2016
Q1 | $1.05M | Sell |
10,171
-9,579
| -49% | -$992K | 0.07% | 231 |
|
|
2015
Q4 | $1.97M | Sell |
19,750
-2,498
| -11% | -$249K | 0.13% | 143 |
|
|
2015
Q3 | $2.03M | Buy |
22,248
+11,175
| +101% | +$1.02M | 0.13% | 147 |
|
|
2015
Q2 | $1.17M | Sell |
11,073
-14,960
| -57% | -$1.59M | 0.07% | 243 |
|
|
2015
Q1 | $2.97M | Sell |
26,033
-464
| -2% | -$52.9K | 0.16% | 141 |
|
|
2014
Q4 | $2.92M | Sell |
26,497
-1,390
| -5% | -$153K | 0.16% | 134 |
|
|
2014
Q3 | $2.72M | Sell |
27,887
-29,046
| -51% | -$2.84M | 0.15% | 145 |
|
|
2014
Q2 | $5.74M | Buy |
56,933
+4,248
| +8% | +$428K | 0.17% | 142 |
|
|
2014
Q1 | $4.84M | Buy |
52,685
+19,004
| +56% | +$1.75M | 0.15% | 156 |
|
|
2013
Q4 | $3.05M | Buy |
33,681
+27,295
| +427% | +$2.47M | 0.08% | 240 |
|
|
2013
Q3 | $509K | Buy |
6,386
+721
| +13% | +$57.5K | 0.01% | 402 |
|
|
2013
Q2 | $412K | Buy |
+5,665
| New | +$412K | 0.01% | 472 |
|